Atlas Trials

Biomarker-driven Therapy for Melanoma

Clinical trial NCT05063058 · COMPLETED

Trial details

NCT number
NCT05063058
Sponsor
Charite University, Berlin, Germany
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Melanoma
Start date
2016-01-01
Primary completion
2019-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.